Clinical trial

Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.

Name
ExSpironUVN
Description
The aim of the study is to evaluate the effect of opioids administered during sedation on patients' respiratory activity (ventilation) and comfort of the operator and patient during the endoscopic procedure. A common side effect of sedation is the effect on patients' ventilation, resulting from a combination of attenuation of respiratory centre activity and loss of patent airways. Shallow sedation will reduce these risks, but in addition to patient discomfort, it also increases the difficulty or impossibility of the endoscopist to perform the procedure. Choosing the appropriate method of sedation thus fundamentally affects the course of the procedure from the point of view of both the patient and the endoscopist. The aim is to prove that sedation with propofol alone compared to sedation with propofol and fentanyl premedication leads to the need for higher cumulative doses of administered propofol, higher risk of respiratory depression and lower patient and operator comfort. In addition, the non-invasive respiratory volume monitor (ExSpiron 2Xi) will be used for standard patient monitoring during the procedure, which assesses the lung tidal volume and respiratory rate by measuring the electrical impedance of the chest. This measurement captures inadequate ventilation before saturation drops, allowing even slight differences between selected drugs to be compared.
Trial arms
Trial start
2023-11-16
Estimated PCD
2024-11-01
Trial end
2024-12-31
Status
Recruiting
Treatment
Sedation using only Propofol.
Patients in whom only propofol will be administered during sedation.
Arms:
Propofol
Other names:
Propofol
Sedation using combination of Propofol and Fentanyl.
Patients in whom combination of propofol and fentanyl will be administered during sedation.
Arms:
Fentanyl
Other names:
Fentanyl
Size
60
Primary endpoint
Incidence of significant decrease in ventilation during propofol sedation.
during the endoscopic procedure
Incidence of significant decrease in ventilation during propofol and fentanyl sedation.
during the endoscopic procedure
Eligibility criteria
Inclusion Criteria: * Scheduled therapeutic or diagnostic colonoscopy with sedation * Supine or lateral decubitus position * Age 18-65 * American Society of Anesthesiologists (ASA) physical status classification system 1-2 * Informed consent signed Exclusion Criteria: * Planned frequent use of electrocoagulation * Contact allergy for adhesive pads, excessive thoracic hair or other problem with pads * contraindication of using Propofol or Fentanyl * Incapability to understand the informed consent
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'The study will be performed on a sample of patients undergoing an endoscopic procedure requiring sedation. Patients will be divided into two groups, one group will be sedated with propofol only, the other will be premedicated with the opioid analgesic fentanyl before the procedure.', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'The endoscopist performing the procedure will not be informed which group the patient belongs to.', 'whoMasked': ['CARE_PROVIDER']}}, 'enrollmentInfo': {'count': 60, 'type': 'ESTIMATED'}}
Updated at
2023-11-18

1 organization

2 products

2 indications

Organization
Charles University
Product
Propofol